Original Query: ALL
Previous Study | Return to List | Next Study

A Study of Onartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Participants With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have Received Chemotherapy For Advanced or Metastatic Disease (MetLung)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01456325
Recruitment Status : Completed
First Posted : October 20, 2011
Last Update Posted : November 2, 2016
Hoffmann-La Roche
Information provided by (Responsible Party):
Genentech, Inc.